Frontiers in pediatrics · 2026
Closed loop construction of hypoglycemia risk management for high risk neonates in mother infant rooming in settings: a retrospective study with an embedded clinical decision support system.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Limin, Shao Hui, Yu Beimeng, Wang Min, Tian Caixia
Аннотация
OBJECTIVE: To evaluate the effectiveness of an intelligent clinical decision support system (CDSS) for neonatal hypoglycemia management in mother-infant rooming-in settings, and to dissect the differential hypoglycemia risk conferred by individual high-risk factors and their specific combinations under standardized surveillance.
METHODS: A multidisciplinary team developed a knowledge-driven CDSS grounded in national expert consensus, integrating automated maternal-neonatal risk identification, dynamic tiered monitoring reminders, and structured stratified management recommendations. Effectiveness was assessed using a pre-post self-controlled analysis (historical control: January-March 2024, n = 522; CDSS-implemented: April-June 2024, n = 417) and a concurrent parallel controlled analysis (non-CDSS wards: n = 389; CDSS wards: n = 352). Neonatal hypoglycemia was defined as blood glucose <2.2 mmol/L. Risk factor combination patterns were explored among 6,667 system-flagged high-risk neonates.
RESULTS: CDSS implementation significantly reduced hypoglycemia incidence in both the pre-post (5.76% vs. 11.88%, P < 0.05) and parallel (5.40% vs. 9.25%, P < 0.05) analyses. Under CDSS-managed surveillance, the overall hypoglycemia incidence in the high-risk cohort was 6.3%. Marked heterogeneity was observed: preterm birth (15.4%) and low birth weight (25.0%) carried the highest independent risks, while risk escalated non-linearly with specific factor combinations, reaching 18.8% in neonates with five concurrent factors. Serial monitoring demonstrated a sharp decline in hypoglycemia incidence from 6.1% at first measurement to ≤0.4% thereafter.
CONCLUSION: The intelligent CDSS effectively reduces neonatal hypoglycemia in rooming-in settings. Hypoglycemia risk depends more on the specific types and combinations of high-risk factors than on their quantity alone, providing evidence for precise risk stratification. This closed-loop, guideline-driven workflow enhances clinical standardization and patient safety. Future multicenter studies incorporating machine learning and long-term neurodevelopmental follow-up are warranted.
METHODS: A multidisciplinary team developed a knowledge-driven CDSS grounded in national expert consensus, integrating automated maternal-neonatal risk identification, dynamic tiered monitoring reminders, and structured stratified management recommendations. Effectiveness was assessed using a pre-post self-controlled analysis (historical control: January-March 2024, n = 522; CDSS-implemented: April-June 2024, n = 417) and a concurrent parallel controlled analysis (non-CDSS wards: n = 389; CDSS wards: n = 352). Neonatal hypoglycemia was defined as blood glucose <2.2 mmol/L. Risk factor combination patterns were explored among 6,667 system-flagged high-risk neonates.
RESULTS: CDSS implementation significantly reduced hypoglycemia incidence in both the pre-post (5.76% vs. 11.88%, P < 0.05) and parallel (5.40% vs. 9.25%, P < 0.05) analyses. Under CDSS-managed surveillance, the overall hypoglycemia incidence in the high-risk cohort was 6.3%. Marked heterogeneity was observed: preterm birth (15.4%) and low birth weight (25.0%) carried the highest independent risks, while risk escalated non-linearly with specific factor combinations, reaching 18.8% in neonates with five concurrent factors. Serial monitoring demonstrated a sharp decline in hypoglycemia incidence from 6.1% at first measurement to ≤0.4% thereafter.
CONCLUSION: The intelligent CDSS effectively reduces neonatal hypoglycemia in rooming-in settings. Hypoglycemia risk depends more on the specific types and combinations of high-risk factors than on their quantity alone, providing evidence for precise risk stratification. This closed-loop, guideline-driven workflow enhances clinical standardization and patient safety. Future multicenter studies incorporating machine learning and long-term neurodevelopmental follow-up are warranted.